Manulife (Manufacturers Life Insurance)
NVO

Manulife (Manufacturers Life Insurance)’s Novo Nordisk NVO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Buy
229,607
+42,361
+23% +$1.82M 0.01% 851
2026
Q1 		$6.88M Buy
187,246
+50,039
+36% +$2.37M 0.01% 1033
2025
Q4 		$7.03M Buy
+137,207
New +$7.02M 0.01% 1049
2025
Q1 		– Sell
-42,251
Closed -$3.63M – 2965
2024
Q4 		$3.63M Sell
42,251
-59,010
-58% -$6.38M ﹤0.01% 1325
2024
Q3 		$12.1M Sell
101,261
-30,615
-23% -$4.08M 0.01% 803
2024
Q2 		$18.8M Buy
131,876
+2,817
+2% +$373K 0.02% 626
2024
Q1 		$16.6M Buy
129,059
+23,861
+23% +$2.84M 0.02% 677
2023
Q4 		$10.9M Buy
105,198
+6,767
+7% +$669K 0.01% 825
2023
Q3 		$8.95M Buy
98,431
+17,187
+21% +$1.51M 0.01% 863
2023
Q2 		$6.57M Buy
81,244
+31,490
+63% +$2.57M ﹤0.01% 956
2023
Q1 		$3.96M Buy
+49,754
New +$3.53M ﹤0.01% 1185
2019
Q1 		– Sell
-1,156,384
Closed -$26.6M – 2641
2018
Q4 		$26.6M Hold
1,156,384
– – 0.03% 445
2018
Q3 		$27.3M Sell
1,156,384
-4,566
-0.4% -$111K 0.03% 480
2018
Q2 		$26.8M Sell
1,160,950
-3,027,566
-72% -$72M 0.03% 508
2018
Q1 		$103M Sell
4,188,516
-1,166
-0% -$30.6K 0.11% 195
2017
Q4 		$112M Sell
4,189,682
-46,378
-1% -$1.18M 0.12% 184
2017
Q3 		$102M Sell
4,236,060
-60,860
-1% -$1.38M 0.12% 180
2017
Q2 		$92.1M Buy
4,296,920
+1,632
+0% +$32.9K 0.11% 183
2017
Q1 		$73.6M Buy
4,295,288
+146,296
+4% +$2.55M 0.09% 229
2016
Q4 		$74.4M Buy
4,148,992
+1,680,620
+68% +$30.5M 0.11% 197
2016
Q3 		$51.3M Buy
2,468,372
+1,744,418
+241% +$43.3M 0.08% 251
2016
Q2 		$19.5M Buy
723,954
+336
+0% +$9.21K 0.03% 458
2016
Q1 		$19.6M Sell
723,618
-2,738
-0.4% -$73.4K 0.02% 458
2015
Q4 		$21.1K Buy
+726,356
New +$20.1M 0.02% 438

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NVO Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Novo Nordisk (NVO) stake by 23% in Q2 2026, buying an estimated $1.82M and bringing the position to 229,607 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #851.

Manulife (Manufacturers Life Insurance) first reported a position in NVO in Q4 2015 and has held it in 24 quarters since. The position peaked at $112M in Q4 2017. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 229,607 shares of Novo Nordisk worth $11M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 42,361 Novo Nordisk shares in Q2 2026, an estimated $1.82M.
  • Novo Nordisk made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #851 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Novo Nordisk in Q4 2015 and has held it in 24 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Novo Nordisk position peaked at $112M in Q4 2017.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.